ANI Pharmaceuticals, Inc. ( ANIP ) was a big mover last session, as the company saw its shares surge 11% on the day. This jump can be attributable to solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company as the stock is now down about 20.2% in the past one-month time frame.
In the last 30 days, the company witnessed 2 downward estimate revisions and the Zacks Consensus Estimate decreased, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent high can last.
ANI Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP
Other attractive players in the med-biomed industry include Actelion Ltd. ( ALIOF
), Illumina Inc. ( ILMN
) and Myriad Genetics Inc. ( MYGN
) all carrying a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days
. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free reportANI PHARMACEUT (ANIP): Free Stock Analysis ReportACTELION LTD (ALIOF): Get Free ReportILLUMINA INC (ILMN): Free Stock Analysis ReportMYRIAD GENETICS (MYGN): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment Research